INVESTABOT
Equity Research
XNYS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Ventas (VTR) had 1 Form 144 pre-sale notice filed on 2026-05-14. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refere…
TL;DR: Peter J. Bulgarelli, Executive Vice President of Outpatient Medical & Research at Ventas, officially separated from the company following his retirement on May 1, 2026. The departure was pre-announced, and a separ…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 8/1/2026 | Wattula Andy | EVP OM&R-Ventas/Pres&CEO-LHS | GRANT | 4,314 | $94 | $403,402 |
| 8/1/2026 | Wattula Andy | EVP OM&R-Ventas/Pres&CEO-LHS | GRANT | 10,694 | $94 | $999,996 |
| 7/16/2026 | Barnes Melody C | — | GRANT | 71.62 | $95 | $6,806 |
| 7/16/2026 | EMBLER MICHAEL J | — | GRANT | 71.62 | $95 | $6,806 |
| 7/16/2026 | LUSTIG MATTHEW J | — | GRANT | 71.62 | $95 | $6,806 |
| 7/16/2026 | LUSTIG MATTHEW J | — | GRANT | 209.67 | $95 | $19,927 |
| 7/16/2026 | Martino Roxanne M | — | GRANT | 173.89 | $95 | $16,526 |
| 7/16/2026 | Rodriguez Joe Vasquez Jr. | — | GRANT | 48.51 | $95 | $4,611 |
| 7/16/2026 | NADER MARGUERITE M | — | GRANT | 71.62 | $95 | $6,806 |
| 7/16/2026 | Roy Sumit | — | GRANT | 71.62 | $95 | $6,806 |
| 7/16/2026 | Roy Sumit | — | GRANT | 47.09 | $95 | $4,475 |
| 7/16/2026 | Smith Maurice S | — | GRANT | 71.62 | $95 | $6,806 |
| 7/16/2026 | Smith Maurice S | — | GRANT | 56.2 | $95 | $5,341 |
| 7/1/2026 | Martino Roxanne M | — | GRANT | 543.78 | $90 | $48,750 |
| 7/1/2026 | Smith Maurice S | — | GRANT | 460.89 | $90 | $41,319 |
| 7/1/2026 | LUSTIG MATTHEW J | — | GRANT | 447.71 | $90 | $40,137 |
| 7/1/2026 | Roy Sumit | — | GRANT | 348.58 | $90 | $31,250 |
| 6/3/2026 | EMBLER MICHAEL J | — | BUY | 2,500 | $79 | $197,025 |
| 5/14/2026 | RAKOWICH WALTER C | — | SELL | -1,152 | $90 | $103,915 |
| 5/13/2026 | Smith Maurice S | — | GRANT | 2,047 | $90 | $184,946 |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 5/14/2026 | J.P. Morgan Securities LLC as agent and attorney-in-fact for Walter C. Rakowich | — | — | SEC |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| 8/4/2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 75,948,003 | $5,876,856,472 | — | 1/29/2026 |
| BlackRock | 55,781,968 | $4,953,438,769 | -1.4% | 8/7/2026 |
| BlackRock | 56,582,774 | $4,627,339,279 | 2.7% | 5/13/2026 |
| BlackRock | 55,092,985 | $4,263,095,169 | — | 2/12/2026 |
| JP Morgan Chase | 43,693,905 | $3,901,865,861 | 22.8% | 8/12/2026 |
| JP Morgan Chase | 35,579,149 | $2,903,970,283 | 25.4% | 5/13/2026 |
| State Street | 30,526,195 | $2,726,267,870 | 2.4% | 8/7/2026 |
| State Street | 29,798,498 | $2,452,081,649 | 0.5% | 5/15/2026 |
| Fidelity (FMR) | 26,246,531 | $2,330,691,910 | -3.7% | 8/13/2026 |
| State Street | 29,662,635 | $2,309,234,430 | — | 2/13/2026 |
| Fidelity (FMR) | 29,281,079 | $2,265,769,881 | — | 2/17/2026 |
| Fidelity (FMR) | 27,251,339 | $2,228,614,392 | -6.9% | 5/15/2026 |
| BlackRock | 43,295,150 | $2,219,309,384 | — | 8/13/2024 |
| JP Morgan Chase | 28,376,464 | $2,195,770,881 | — | 2/11/2026 |
| Morgan Stanley | 7,885,794 | $700,258,761 | 23.5% | 8/13/2026 |
| Morgan Stanley | 6,387,470 | $522,367,581 | 0.7% | 5/15/2026 |
| Morgan Stanley | 6,344,347 | $490,925,761 | — | 5/27/2026 |
| Goldman Sachs | 4,813,407 | $427,430,576 | 14.3% | 8/14/2026 |
| Goldman Sachs | 4,211,923 | $344,451,074 | 2.7% | 5/15/2026 |
| Two Sigma | 4,002,405 | $327,316,681 | 146.3% | 5/15/2026 |